• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尼日利亚伊巴丹青少年哮喘症状的患病率和严重程度降低,1995-2018 年。

Decreased prevalence and severity of asthma symptoms among adolescents in Ibadan, Nigeria, 1995-2018.

机构信息

Department of Paediatrics, College of Medicine, University of Ibadan, Ibadan, Department of Paediatrics, University College Hospital, Ibadan, Nigeria.

Kwame Nkrumah University of Science and Technology, Kumasi, Komfo Anokye Teaching Hospital, Kumasi, Ghana.

出版信息

Int J Tuberc Lung Dis. 2023 Dec 1;27(12):925-930. doi: 10.5588/ijtld.23.0138.

DOI:10.5588/ijtld.23.0138
PMID:38042979
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10719893/
Abstract

Phases I and III of the International Study of Asthma and Allergies in Childhood (ISAAC) documented increased asthma symptoms among Nigerian 13-14-year old adolescents. We investigated the trend further using the Global Asthma Network (GAN) surveillance. Using ISAAC methodology, GAN Phase I data on symptoms and risk factors for asthma and asthma management were obtained from February to July 2018. There were 2,897 adolescents from 23 secondary schools. For current wheeze, there was an absolute prevalence fall per decade of -1.4 with -1 standard error (SE) in 16 years from 2002 (ISAAC Phase III) to 2018 (GAN Phase I). This pattern was evident for prevalence of reported asthma ever, severe asthma symptoms and night cough with ≥1 SE. During the 23-year interval between ISAAC Phase I and GAN Phase I, there was a fall (≥1 SE) in the absolute prevalence of reported asthma ever, severe asthma symptoms and night cough, except for severe asthma symptoms (-0.2 SE). Respectively 36% and 43% of symptomatic adolescents purchased and used salbutamol and prednisolone. The prevalence and severity of asthma symptoms remain high among adolescents in Ibadan. This could be mitigated by improved access to affordable and effective asthma treatments.

摘要

国际儿童哮喘和过敏研究(ISAAC)的 I 期和 III 期研究记录了尼日利亚 13-14 岁青少年哮喘症状的增加。我们使用全球哮喘网络(GAN)监测进一步调查了这一趋势。使用 ISAAC 方法,从 2018 年 2 月至 7 月获得了 GAN 阶段 I 关于哮喘症状和危险因素以及哮喘管理的数据。共有来自 23 所中学的 2897 名青少年。对于当前喘息,从 2002 年(ISAAC III 期)到 2018 年(GAN 期 I)的 16 年中,每十年的绝对患病率下降了 1.4,标准差(SE)为 1.4。对于报告的哮喘史、严重哮喘症状和夜间咳嗽≥1 SE,这种模式明显存在。在 ISAAC 第一阶段和 GAN 第一阶段之间的 23 年间隔内,报告的哮喘史、严重哮喘症状和夜间咳嗽的绝对患病率均有所下降(≥1 SE),但严重哮喘症状除外(-0.2 SE)。分别有 36%和 43%的有症状青少年购买并使用沙丁胺醇和泼尼松龙。伊巴丹青少年的哮喘症状发生率和严重程度仍然很高。通过改善获得负担得起和有效的哮喘治疗的机会,可以减轻这种情况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0f9/10719893/928596ac7b34/i1815-7920-27-12-925-f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0f9/10719893/36559fe48d15/i1815-7920-27-12-925-f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0f9/10719893/928596ac7b34/i1815-7920-27-12-925-f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0f9/10719893/36559fe48d15/i1815-7920-27-12-925-f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0f9/10719893/928596ac7b34/i1815-7920-27-12-925-f02.jpg

相似文献

1
Decreased prevalence and severity of asthma symptoms among adolescents in Ibadan, Nigeria, 1995-2018.尼日利亚伊巴丹青少年哮喘症状的患病率和严重程度降低,1995-2018 年。
Int J Tuberc Lung Dis. 2023 Dec 1;27(12):925-930. doi: 10.5588/ijtld.23.0138.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Systematic review of worldwide variations of the prevalence of wheezing symptoms in children.儿童喘息症状患病率全球差异的系统评价
Environ Health. 2008 Nov 10;7:57. doi: 10.1186/1476-069X-7-57.
4
Safety of regular formoterol or salmeterol in children with asthma: an overview of Cochrane reviews.福莫特罗或沙美特罗常规用药对哮喘儿童的安全性:Cochrane系统评价综述
Cochrane Database Syst Rev. 2012 Oct 17;10(10):CD010005. doi: 10.1002/14651858.CD010005.pub2.
5
Intramuscular versus oral corticosteroids to reduce relapses following discharge from the emergency department for acute asthma.肌肉注射与口服皮质类固醇用于减少急性哮喘患者从急诊科出院后的复发情况。
Cochrane Database Syst Rev. 2018 Jun 2;6(6):CD012629. doi: 10.1002/14651858.CD012629.pub2.
6
Combination formoterol and budesonide as maintenance and reliever therapy versus combination inhaler maintenance for chronic asthma in adults and children.福莫特罗与布地奈德联合用于成人和儿童慢性哮喘的维持和缓解治疗与联合吸入器维持治疗的对比
Cochrane Database Syst Rev. 2013 Dec 16;2013(12):CD009019. doi: 10.1002/14651858.CD009019.pub2.
7
Safety of regular formoterol or salmeterol in adults with asthma: an overview of Cochrane reviews.成人哮喘患者使用福莫特罗或沙美特罗常规剂型的安全性:Cochrane系统评价综述
Cochrane Database Syst Rev. 2014 Feb 6;2014(2):CD010314. doi: 10.1002/14651858.CD010314.pub2.
8
A New Measure of Quantified Social Health Is Associated With Levels of Discomfort, Capability, and Mental and General Health Among Patients Seeking Musculoskeletal Specialty Care.一种新的量化社会健康指标与寻求肌肉骨骼专科护理的患者的不适程度、能力以及心理和总体健康水平相关。
Clin Orthop Relat Res. 2025 Apr 1;483(4):647-663. doi: 10.1097/CORR.0000000000003394. Epub 2025 Feb 5.
9
Honey for acute cough in children.蜂蜜用于治疗儿童急性咳嗽。
Cochrane Database Syst Rev. 2018 Apr 10;4(4):CD007094. doi: 10.1002/14651858.CD007094.pub5.
10
Urodynamics tests for the diagnosis and management of male bladder outlet obstruction: long-term follow-up of the UPSTREAM non-inferiority RCT.用于男性膀胱出口梗阻诊断和管理的尿动力学检查:UPSTREAM非劣效性随机对照试验的长期随访
Health Technol Assess. 2025 Jul;29(26):1-57. doi: 10.3310/SLPT4675.

引用本文的文献

1
Association of individual and environmental factors exposure with asthma among children: a cross-sectional study in Northern and Southern cities, China.儿童个体及环境因素暴露与哮喘的关联:中国南北城市的一项横断面研究
BMC Public Health. 2025 May 1;25(1):1610. doi: 10.1186/s12889-025-22842-w.

本文引用的文献

1
Improving access to affordable quality-assured inhaled medicines in low- and middle-income countries.改善中低收入国家获得负担得起的、有质量保证的吸入性药物的途径。
Int J Tuberc Lung Dis. 2022 Nov 1;26(11):1023-1032. doi: 10.5588/ijtld.22.0270.
2
The availability, cost, and affordability of essential medicines for asthma and COPD in low-income and middle-income countries: a systematic review.中低收入国家哮喘和 COPD 基本药物的可及性、成本和可负担性:系统评价。
Lancet Glob Health. 2022 Oct;10(10):e1423-e1442. doi: 10.1016/S2214-109X(22)00330-8.
3
Asthma management in low and middle income countries: case for change.
低收入和中等收入国家的哮喘管理:变革的理由。
Eur Respir J. 2022 Sep 15;60(3). doi: 10.1183/13993003.03179-2021. Print 2022 Sep.
4
The burden of asthma, hay fever and eczema in adults in 17 countries: GAN Phase I study.17 个国家成年人哮喘、花粉热和湿疹负担:GAN 阶段 I 研究。
Eur Respir J. 2022 Sep 15;60(3). doi: 10.1183/13993003.02865-2021. Print 2022 Sep.
5
The burden of asthma, hay fever and eczema in children in 25 countries: GAN Phase I study.25 个国家儿童哮喘、花粉症和湿疹负担:GAN 阶段 I 研究。
Eur Respir J. 2022 Sep 15;60(3). doi: 10.1183/13993003.02866-2021. Print 2022 Sep.
6
Worldwide trends in the burden of asthma symptoms in school-aged children: Global Asthma Network Phase I cross-sectional study.全球范围内学龄期儿童哮喘症状负担的趋势:全球哮喘网络第一阶段横断面研究。
Lancet. 2021 Oct 30;398(10311):1569-1580. doi: 10.1016/S0140-6736(21)01450-1. Epub 2021 Oct 28.
7
Improving lung health in low-income and middle-income countries: from challenges to solutions.改善中低收入国家的肺部健康:从挑战到解决方案。
Lancet. 2021 Mar 6;397(10277):928-940. doi: 10.1016/S0140-6736(21)00458-X. Epub 2021 Feb 22.
8
Nationwide survey of the availability and affordability of asthma and COPD medicines in Nigeria.尼日利亚哮喘和 COPD 药物的供应和可负担性的全国性调查。
Trop Med Int Health. 2021 Jan;26(1):54-65. doi: 10.1111/tmi.13497. Epub 2020 Oct 14.
9
Calling time on asthma deaths in tropical regions-how much longer must people wait for essential medicines?叫停热带地区的哮喘死亡——人们等待基本药物还需多久?
Lancet Respir Med. 2019 Jan;7(1):13-15. doi: 10.1016/S2213-2600(18)30513-7. Epub 2018 Dec 12.
10
The Global Asthma Network rationale and methods for Phase I global surveillance: prevalence, severity, management and risk factors.全球哮喘网络第一阶段全球监测的原理和方法:流行率、严重程度、管理和危险因素。
Eur Respir J. 2017 Jan 11;49(1). doi: 10.1183/13993003.01605-2016. Print 2017 Jan.